Insulin
No structure available
Insulin could not be matched to a single known compound.
Listing
- Schedules
- Schedule 3
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
3 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Insulin | Apidra, Actrapid hm (ge) | 1 mL, 100 units | 2 applicants | 2 registrations | S3 |
9 more registered products name Insulin in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Humalog | Humalog | 100 units/ml | Eli Lilly (S.A.) (Pty) Ltd | 290785 | S3 |
| Humalog Mix | Humalog mix | 25, 50 | Eli Lilly (S.A.) (Pty) Ltd | 2 registrations | S3 |
| Humalog Kwikpen Cancelled | Humalog kwikpen | 200 units/ml | Eli Lilly (S.A.) (Pty) Ltd | 500680 | S3 |
| Admelog Cancelled | Admelog | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 550094 | S3 |
| Insulin Lispro Sanofi Cancelled | Insulin lispro sanofi | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 550095.094 | S3 |
| Lyumjev U100 Cancelled | Lyumjev u100 | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 560047 | S3 |
| Lyumjev U200 Cancelled | Lyumjev u200 | 200 units/mL | Eli Lilly (S.A.) (Pty) Ltd | 560048 | S3 |
| Lyumjev Junior U100 Cancelled | Lyumjev junior u100 | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 560049 | S3 |
| Bemliru U100 Cancelled | Bemliru u100 | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 560050.047 | S3 |
| Bemliru U200 Cancelled | Bemliru u200 | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 560051.048 | S3 |
| Bemliru Junior U100 Cancelled | Bemliru junior u100 | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 560052.049 | S3 |
| Novorapid | Novorapid | 100 U/mL | Novo Nordisk (Pty) Ltd û (Rivonia) | 340160 | S3 |
Show the other 18 registered products
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Novomix | Novomix | 100 U/ml | Novo Nordisk (Pty) Ltd û (Rivonia) | 350031 | S3 |
| Fiasp | Fiasp | 100 U/ml | Novo Nordisk (Pty) Ltd û (Rivonia) | 510733 | S3 |
| Truvelog Cancelled | Truvelog | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 550513 | S3 |
| Lantus | Lantus | 000 IU/10 ml 1, 3.64mg / 1ml, 500 IU/5 ml | Sanofi-aventis South Africa (Pty) Ltd | 3 registrations | S3 |
| Optisulin | Optisulin | 100 IU/mL | Sanofi-aventis South Africa (Pty) Ltd | 410363 | S3 |
| Basaglar | Basaglar | Not stated | Eli Lilly (S.A.) (Pty) Ltd | 490708 | S3 |
| Tusjorus Cancelled | Tusjorus | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 491229 | S3 |
| Toujeo | Toujeo | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 491230 | S3 |
| Endulin Cancelled | Endulin | Not stated | Viatris South Africa (Pty) Ltd | 500940 | S3 |
| Endulin Select Cancelled | Endulin select | Not stated | Viatris Healthcare (Pty) Ltd | 510729 | S3 |
| Insulin Glargine Mylan Cancelled | Insulin glargine mylan | Not stated | Viatris Healthcare (Pty) Ltd | 510730.729 | S3 |
| Levemir | Levemir | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 380084 | |
| Gluliwin Cancelled | Gluliwin | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 410349 | |
| Tresiba | Tresiba | 100 U/ml, 200 U/ml | Novo Nordisk (Pty) Ltd û (Rivonia) | 2 registrations | S3 |
| Ryzodeg | Ryzodeg | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 470165 | S3 |
| Xultophy Cancelled | Xultophy | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 500985 | S3 to S4 |
| Soliqua | Soliqua | 33/100, 50/100 | Sanofi-aventis South Africa (Pty) Ltd | 2 registrations | S3 to S4 |
| Vivsuna Cancelled | Vivsuna | 33/100, 50/100 | Sanofi-aventis South Africa (Pty) Ltd | 2 registrations | S3 to S4 |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Insulin
S3: Insulin
Consolidated Schedules 06 July 2026, line 3794
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.